KMTS compared with KLRA: revenue, margins and what each company keeps, and the suppliers and customers both name

KMTSKestra Medical Technologies, Ltd.

Mkt capRevenueRevenue

KLRAKailera Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

KMTSKestra Medical Technologies, Ltd.

KLRAKailera Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KMTS

Reportimpliedrealized× implied

Sep 15 '26—▲+4.66%—

Q1 FY26—▲+1.80%—

Q3 FY26—▼−7.38%—

Dec 12 '25—▲+5.06%—

KLRA2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±33.0%▼−4.92%×0.15

Q2 FY26—▼−3.34%

= impliedKMTS realized, solidKLRA realized, hatchedOne scale, both sides: full bar = 34%× = |realized| ÷ impliedspan: KMTS 277d · KLRA 84dSource: market data

—

KMTSKestra Medical Technologies, Ltd.

28.38▼−0.53%

Mkt cap$1.7BRevenue$25MQ3 FY26Revenue$60MFY25

KLRAKailera Therapeutics, Inc.

12.43▲+2.15%

Regular sessionNov 6 '26

Mkt cap$1.7BRevenue—Revenue—

Compare

Regular sessionNov 6 '26

KMTSKestra Medical Technologies, Ltd.

KLRAKailera Therapeutics, Inc.

28.38▼−0.53%

Price

12.43▲+2.15%

$1.7B

Mkt cap

$1.7B

Q3 FY26$25M

Revenue

—

FY25$60M

Revenue

—

KMTS28.38▼−0.53%vsKLRA12.43▲+2.15%Regular sessionNov 6 '26